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Abstract
Background: Recent functional studies have demonstrated that many microRNAs (miRNAs) are expressed by RNA
polymerase II in a specific spatiotemporal manner during the development of organisms and play a key role in
cell-lineage decisions and morphogenesis. They are therefore functionally related to a number of key protein coding
developmental genes, that form genomic regulatory blocks (GRBs) with arrays of highly conserved non-coding
elements (HCNEs) functioning as long-range enhancers that collaboratively regulate the expression of their target
genes. Given this functional similarity as well as recent zebrafish transgenesis assays showing that the miR-9 family is
indeed regulated by HCNEs with enhancer activity, we hypothesized that this type of miRNA regulation is prevalent.
In this paper, we therefore systematically investigate the regulatory landscape around conserved self-transcribed
miRNAs (ST miRNAs), with their own known or computationally inferred promoters, by analyzing the hallmarks of
GRB target genes. These include not only the density of HCNEs in their vicinity but also the presence of large CpG
islands (CGIs) and distinct patterns of histone modification marks associated with developmental genes.
Results: Our results show that a subset of the conserved ST miRNAs we studied shares properties similar to those
of protein-coding GRB target genes: they are located in regions of significantly higher HCNE/enhancer binding
density and are more likely to be associated with CGIs. Furthermore, their putative promoters have both activating
as well as silencing histone modification marks during development and differentiation. Based on these results we
used both an elevated HCNE density in the genomic vicinity as well as the presence of a bivalent promoter to
identify 29 putative GRB target miRNAs/miRNA clusters, over two-thirds of which are known to play a role during
development and differentiation. Furthermore these predictions include miRNAs of the miR-9 family, which are the
only experimentally verified GRB target miRNAs.
Conclusions: A subset of the conserved miRNA loci we investigated exhibits typical characteristics of GRB target
genes, which may partially explain their complex expression profiles during development.
Background
MicroRNAs (miRNAs) are small RNAs (~ 22 nt) found
in plants, animals, viruses and at least one unicellular
organism (Chlamydomonas reinhardtii) [1]. They func-
tion by binding to target sites in 3’’ UTRs of messenger
RNAs (mRNAs) to repress translation or mediate
mRNA degradation, although alternative modes of
action have been reported recently, such as direct
transcriptional silencing of POLR3D by miR-320 [2]. In
animals, the majority of mature miRNAs are synthesized
in two processing steps: first, the primary miRNA tran-
script (pri-miRNA) is cut by the nuclear RNase III
enzyme Drosha and its cofactor DGCR8 in the nucleus,
generating precursor miRNAs (pre-miRNAs). These are
subsequently exported to the cytoplasm via the nuclear
transport receptor exportin-5 and the co-factor RanGTP,
where they are cleaved by the RNase III enzyme Dicer
into a double stranded RNA of ~22nt. The strand with
the less stable 5’’ hydrogen bonding is usually selected
as the mature miRNA, although both strands can be
functional. It is assumed that the pri-miRNAs of most
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intergenic miRNAs are transcribed independently by
RNA polymerase II (Pol II) [3], while most intragenic
miRNAs are co-transcribed with their host genes. Given
the similarity with class II protein-coding genes, their
expression may be controlled through a variety of
shared regulation pathways. However, few pri-miRNAs
have been characterized experimentally to date [3-8],
making the localization of their promoters challenging
and one of the prime reasons we are only beginning to
understand the mechanism by which their expression is
regulated. Recently, several studies attempted to predict
the primary transcripts of pri-miRNAs by exploring
transcription factor binding sites (TFBSs), expressed
sequence tags (ESTs), transcription start site (TSS) pre-
dictions, and further, complementary genomic data
[9-15]. Based on these studies, the length of pri-miRNAs
was estimated to range from several hundred to several
thousand nucleotides. These studies are useful refer-
ences to estimate the scale of pri-miRNAs as well as the
location of their promoter, in order to investigate
miRNA transcriptional regulation.
miRNAs can be expressed in a tissue- and stage-speci-
fic manner during development and that they can play
key roles in lineage decisions of progenitor cells and
organogenesis (reviewed in [16]). Enhancer-mediated
long-range regulation is an important mechanism for
controlling gene expression during development and has
recently been shown to affect miRNAs as well [17].
Many of these enhancers are highly conserved non-cod-
ing elements (HCNEs) that collaboratively regulate the
specific expression of their respective target genes
[18-24]. It has previously been demonstrated that both
HCNEs and their target genes are preserved within syn-
teny blocks in vertebrates and insects during evolution,
which has served as the foundation for the concept of
the “genomic regulatory block” (GRB). GRBs are func-
tional regulatory units that consist of HCNEs, genes
regulated by HCNEs ("target genes”) as well as “unre-
lated” genes ("bystander genes”). Both HCNEs and target
genes have coevolved in order to maintain their func-
tional association, while bystander genes can be lost
through the time.
Further investigation of the general transcriptional
initiation properties of genes in GRBs has shown that
the promoters of GRB target genes share common fea-
tures that can be used to distinguish them from the pro-
moters of bystander genes, which are genes that may be
close to, or even harbor, HCNEs but are not under their
regulation. Target genes are generally associated with
long CpG islands (CGIs) that are not limited to the 5’
end of the genes, but also occur in introns or internal
exons of the gene [25] and coincide with genomic
regions bound by repressor Polycomb group proteins
[26]. In addition, they have a higher number and wider
spacing of alternative TSSs, and a distinct composition
of TFBSs in their core/proximal promoters [25].
Furthermore, many target gene promoters belong to the
class of “bivalent promoters” that display a distinct pat-
tern of both activating and repressing histone modifica-
tions in embryonic stem (ES) cell lines [25], which may
allow them to be turned on or off quickly during orga-
nogenesis [27,28]. The analysis of the mir-9 miRNA
family members (dre-mir-9-5 and ) dre-mir-9-1) in zebra-
fish has shown that they are regulated by the same type of
enhancers as protein-coding GRB target genes [17]. These
miRNA target genes are both embedded in areas of con-
served synteny throughout vertebrates and co-localize
with a number of HCNEs that function as long-range
enhancers controlling their expression. As a result, they
show highly stage- and tissue-specific expression in dorsal
telencephalon at 24 h post fertilization, while the expres-
sion pattern of the neighboring bystander genes is far less
specific. The inspection of other miRNAs in the Ancora
genome browser [29] clearly reveals further examples of
miRNAs that fall within regions of high HCNE density,
such as hsa-mir-124-2, indicating that this type of regula-
tion may be prevalent.
Based on their functional similarity and the common
transcriptional mechanisms they employ, we hypothesize
that miRNAs with complex spatiotemporal expression
patterns may be regulated in the same manner as pro-
tein-coding GRB target genes and that they share the
following genomic properties:
- a genomic neighborhood with a high HCNE
density
- a bivalent promoter [28] during development and
differentiation
- large CGIs spanning both the promoter and the
gene body
In our work we show that both a subset of conserved
self-transcribed miRNAs (ST miRNAs) as well as a set
of experimentally validated GRB target miRNAs [17]
demonstrate these properties. But our ability to use
these features for predicting novel GRB target miRNAs
was limited, since more than half of the ST miRNAs in
our dataset do not have primary transcript predictions
and we were therefore not able to accurately compute
CpG island-related features for them. As a result, we
used an elevated HCNE density in the genomic vicinity
as well as the presence of a bivalent promoter to then
identify 29 putative GRB target miRNAs/miRNA clus-
ters, over two-thirds of which are known to play a role
during development and differentiation. Furthermore
these predictions include miRNAs of the miR-9 family,
which are the only experimentally verified GRB target
miRNA genes.
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Results and Discussion
Defining self-transcribed miRNAs and the extent of their
pri-mRNAs
Based on the assumption that some miRNAs have co-
evolved with their cis-acting regulatory elements, in this
study, we focused on conserved human self-transcribed
miRNAs (ST miRNAs), which are assumed to be tran-
scribed from their own promoters and have an ortholog
in at least one other vertebrate species (Additional file 1,
Table S1). These requirements are consistent with the
work describing the original definition of a GRB [17] as
well as the subsequent analysis of the features of GRB
target genes [25]. In general, ST miRNAs include all
conserved human intergenic miRNAs except those tran-
scribed by RNA polymerase III (Pol III) [30], as well as
known cases of intronic miRNAs whose fate after
whole-genome duplication in fish indicates that they
have their own promoters, independent of their host
genes (see Methods).
Since proximal miRNAs can appear in genomic clus-
ters that share the same promoter and are transcribed
as a single transcript, we clustered ST miRNAs accord-
ing to their genomic vicinity (see Methods) and analyzed
only one promoter per cluster,
The annotation of the pri-miRNAs we used in this
study was the result of a combinatorial approach by
Saini et al. [14] that employed predicted and experimen-
tal evidence to identify both transcription start and end
sites. One of the most important reasons for choosing
this dataset was the fact that they considered a larger
range of possible miRNA sizes, thereby avoiding biases
introduced by excluding very long transcripts. We esti-
mated the general scale of pri-miRNAs based on these
data, where the TSS is within 50 kb upstream of pre-
miRNAs and the transcription end is within 20 kb
downstream of the pre-miRNAs. This approach was
sensitive enough to include around 84% of the pri-miR-
NAs in the initial dataset (see Figure 1 and Methods).
Enhancer density
HCNEs
HCNEs represent putative enhancers of gene expression,
whose frequency rises strongly around the conserved
developmental genes they usually target [17,22]. We
therefore first investigated whether this applied to con-
served ST miRNAs as well, by comparing the HCNE
density in a 300 kb window centered on the ST miRNA
with random coding and non-coding genomic regions
with similar gene density (see Methods). In a few cases
(~8%), the location of the ST miRNA search window
overlapped with a previously defined GRB making it dif-
ficult to identify the actual target gene, which could
either be the miRNA, the annotated GRB target gene, or
both. For this reason, we compared the HCNE densities
both including and excluding cases in which the ST
miRNA search window overlapped with a previously
defined GRB. As shown in Table 1, the HCNE density
was significantly higher around ST miRNAs than the
random coding and non-coding regions in both compar-
isons, a trend that is independent of the lineages com-
pared (p-value ≤ 0.05, two-sided bootstrapped version of
the Kolmogorov-Smirnov test: see Table 1, Figure 2 as
well as Additional files 2 and 3). Thus, in support of our
original hypothesis, we can conclude that HCNEs are
highly over-represented in the genomic vicinity of con-
served human ST miRNAs. The HCNE density was also
compared between the conserved ST miRNAs and the
GRB target genes annotated in Akalin et al. [25]. We
found that the HCNE density was significantly lower for
the ST miRNAs (p-value ≤ 0.05, two-sided bootstrapped
version of the Kolmogorov-Smirnov test: see Table 1,
Figure 2 as well as Additional files 2 and 3). This is due
to the fact that the GRB target genes were annotated
based on their high HCNE density [25], which was not
a prerequisite for constructing our dataset of ST
miRNAs.
Experimentally verified enhancers
In addition to HCNEs, we utilized experimental data
describing the location of the transcriptional co-activa-
tor p300 to analyze the enhancer density around ST
miRNAs. This transcription factor is a ubiquitous com-
ponent of enhancer-associated protein assemblies. It co-
localizes with active enhancers and plays a critical role
during embryonic development [31-36]. Visel et al. [36]
mapped the genome-wide binding of p300 in forebrain,
midbrain and limb tissue of developing mouse embryos
using ChIP-seq technology. This generated ~5000 p300
binding regions which are associated with active enhan-
cers. Since conservation criteria did not play a role in
determining these p300 binding regions, they represent
a dataset of experimentally verified enhancers that is
completely independent of the HCNEs, allowing us to
test our hypothesis in an unbiased manner. We then
compared the p300 binding density around ST miRNAs
that are conserved between mouse and human (mouse:
human) with that of mouse coding and non-coding
regions using the same method as the previous HCNE
density analysis and found that the density of p300
binding sites around mouse:human ST miRNAs was
indeed significantly higher than in the control sets
(p-value < 1e-20 for both comparisons, two-sided
bootstrapped version of the Kolmogorov-Smirnov test)
(Figure 3).
These results are independent of HCNE density, since
the same trend was still present when we performed the
analysis excluding p300 binding sites that overlap with
mouse orthologs of our HCNEs (p-value < 1e-20 for
both comparisons, two-sided bootstrapped version of
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Figure 1 Density distribution of distances between predicted TSSs/TESs and human pre-miRNAs. The corresponding dashed lines indicate
the cutoffs used to define the TSSs and TESs in the analysis, whose distance distributions are indicated by the red and blue curves, respectively.
Table 1 HCNE density comparison
Comparison between human
conserved ST miRNAs and human
random coding regions
Comparison between human
conserved ST miRNAs and human
random non-coding regions
Comparison between human conserved ST
miRNAs and human GRB target genes
Lineage
comparison
p-value
(all
regions)
p-value (excluding
regions overlapping
GRBs)
p-value
(all
regions)
p-value (excluding
regions overlapping
GRBs)
p-value
(all
regions)
p-value (excluding conserved
human ST miRNAs overlapping
GRBs)
human:
mouse
0 0 0 0 0 0
human: dog 0 0 0 0 0 0
human:
opossum
0 0 1.0e-04 0 0 0
human:
platypus
0 0 0 2.0e-04 0 0
human:
chicken
0 0 0 0 0 0
human: frog 0 0 0 0 0 0
human:
zebrafish
4.0e-03 8.0e-03 1.8e-03 4.0e-04 0 0
The comparisons represented by each column were performed after selecting HCNEs and ST miRNAs conserved between the lineages shown in the left column
(see Methods). The p-values were computed using the two-sided bootstrapped version of the Kolmogorov-Smirnov test. All p-values lower than 1.0e-20 were set
to 0.
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the Kolmogorov-Smirnov test) (Figure 3, Additional file 4
and Table S2).
Comparison between enhancer enriched and enhancer
poor ST miRNAs
As the density of HCNEs/p300 binding around con-
served ST miRNAs is significantly higher than in ran-
dom non-coding and protein coding regions and there
are conserved ST miRNAs that are known developmen-
tal regulators similar to GRB target genes, we wanted to
see whether there was an association between the indivi-
dual features of GRB target genes and HCNE/p300 den-
sities. We again limited the analysis to ST miRNAs
conserved between human and mouse in order to be
able to incorporate the p300 binding data.
We then compared the features of GRB target genes
between the HCNE/p300 enriched and HCNE/p300
poor miRNAs excluding intragenic ST miRNAs due to
the uncertainty in associating genomic features with the
ST miRNA or the host gene.
Identification and analysis of bivalent ST miRNA promoters
The genome-wide mapping of chromatin states by detec-
tion of histone marks revealed regions carrying both the
H3K4me3 and H3K27me3 histone modifications.
Although these so-called bivalent domains [27] are rare
within the genome, they are over-represented at the pro-
moters of key developmental genes (bivalent promoters)
in embryonic stem cells [28] and were suggested to med-
iate activation and repression of expression of the genes
during lineage commitment by maintaining genes in a
poised status [27]. Furthermore, bivalent promoters repre-
sent useful marks for the annotation of both protein-cod-
ing and miRNA GRB target genes, since around 70% of
them had a bivalent promoter in mouse ES cells,
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Figure 2 The enrichment of HCNEs around conserved human ST miRNAs (including ST miRNAs overlapping with GRBs). Figure 2 shows
the cumulative curves of HCNE density in five lineage comparisons. The lineages compared are indicated at the top of each figure. The HCNE
density was calculated based on a 300 kb window centered on a region of interest, which is either a ST miRNA, a randomly selected coding/
non-coding region (control sets) or a GRB target gene. The x-axis shows the percentage of base pairs in HCNEs within the 300 kb window
(HCNE density). The fraction of 300 kb windows we analyzed is shown in the y-axis. The red curve shows the HCNE density of the conserved
human ST miRNAs, while the grey, blue and green curves show the HCNE density of the non-coding and protein-coding control sets as well as
the set of GRB target genes, respectively. Conserved human ST miRNAs are therefore more likely to be located in regions with higher HCNE
density than would be expected by chance.
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compared to only 13% of the bystander genes [25], and the
expression of several lineage-specific miRNAs is correlated
with the presence of this mark at their promoters [28].
Both human [37] and mouse bivalent domains [28]
were subsequently mapped to the putative promoter
regions of HCNE enriched/poor ST miRNAs and p300
enriched/poor ST miRNAs, respectively (see Methods).
We found that 24% (15/63) of the HCNE enriched ST
miRNAs are associated with bivalent domains within 50
kb upstream in human ES cells, compared to only 8%
(5/62) of HCNE poor ST miRNAs (p-value = 0.03, one
side Fisher’’s exact test). However, bivalent domains are
less likely to be associated with p300 enriched ST miR-
NAs compared to those of p300 poor ST miRNAs (10/
62 versus 19/61). This difference could be explained by
the fact that the data on histone modifications and p300
binding are from different tissues/developmental stages,
since the histone modification data are from V6.5 ES
cells, hybrid ES cells, Neural Progenitor cells (NPCs)
and primary Embryonic Fibroblasts (MEFs) obtained at
embryonic day (E) 13.5 [28], while the p300 data is from
embryonic forebrain, midbrain and limb tissue of mouse
embryos at E 11.5 [36]. As enhancers and histone modi-
fications are both tissue- and stage-specific, it is possible
that the p300 data and bivalent domains we used in the
analysis regulate transcription in distinct developmental
contexts. Furthermore, the bivalent promoters are asso-
ciated with promoters “poised” for transcription [27]
while the p300 marks of active enhancers are expected
to co-occur with actively transcribed target genes [38],
so they are unlikely to co-occur in the same tissue/stage
for a given gene. Fortunately, the detection of HCNEs
does not rely on tissue or developmental stages, but
instead is able to detect putative enhancers in all tissues
from all stages. Therefore, the analysis of HCNE
enriched/poor ST miRNAs is stage/tissue-independent
and thus less likely to be biased. For this reason, in the
following analysis we only compared features between
HCNE enriched and HCNE poor ST miRNAs.
Analysis of CpG islands associated with ST miRNAs
GRB target genes are often associated with higher ratios
between CGI length and transcript length (CpG-to-gene
ratio), and the overlapping CGIs map not only to the
promoter, as in most other genes, but also introns,
internal exons, and in some cases, even cover the entire
target gene [25]. It was shown recently that some of
these CGIs coincide within genomic regions bound by
repressive Polycomb Group proteins (PcG-proteins)
[26]. A recent study also found that 21 human miRNAs
co-localized with multiple CGIs within their 10 kb
flanking regions, and that 25 pre-miRNAs were comple-
tely embedded in CGIs [12]. In addition, Juan et al. [39]
showed that the expression of miR-199/214 might be
regulated by PcG-proteins during skeletal muscle cell
differentiation. In another example shown by Wang et
al. miR-29 is repressed by NF-kappaB acting through
YY1 and the PcG-proteins [40]. Based on these findings,
we compared the CpG-to-gene ratio associated with
HCNE enriched and HCNE poor ST miRNAs as well as
the gene sets used in the previous GRB target gene
study by Akalin et al [25] (see Methods).
The results show that the CpG-to-gene ratio of the
HCNE enriched ST miRNAs is significantly higher than
those of bystander, transcription factor and CGI-
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Figure 3 The enrichment of p300 binding sites around mouse orthologs of human ST miRNAs. Figure 3 shows the cumulative curves of
the enhancer enrichment analysis using all p300 binding sites (A) and using only p300 binding sites that do not overlap HCNEs conserved
between human and mouse (percentage of identity ≥ 98% and length of HCNE ≥ 50 bp) (B). These results indicate that the mouse orthologs of
human ST miRNAs are more likely to be located in regions with significantly higher p300 binding site density than the control set of protein
coding and non-coding regions.
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associated genes, while there is no significant difference
in the comparison with the GRB target genes (Table 2).
Furthermore, we find no significant differences in the
CpG-to-gene ratios between HCNE poor ST miRNAs
and bystander genes or other transcription factors. In
addition, the CpG-to-gene ratios of HCNE poor ST
miRNAs is significantly lower when compared to GRB
target genes/other CGI genes. This indicates that the
distribution of CpG-to-gene ratios of HCNE enriched
ST miRNAs is more similar to GRB target genes than
that of HCNE poor ST miRNAs. However, we did not find
significant differences in the CpG-to-gene ratios between
HCNE enriched ST miRNAs and HCNE poor ST miR-
NAs, which could be explained by the small sample size.
Nevertheless, there is still a common trend showing that
HCNE enriched ST miRNAs have higher CpG-to-gene
ratios than HCNE poor ST miRNAs, since their median
CpG-to-gene ratio is fivefold higher (Table 2).
GRB target gene features can identify ST miRNAs subject
to long-range regulation
The miR-9 family of miRNAs is a known, experimentally
verified GRB target [17] and therefore a prime example for
illustrating how the genomic features we analyzed could
serve to annotate miRNAs under long-range regulation.
This family is specifically expressed in brain and affects
the fate of ES cell-derived neural precursor cells differen-
tiating along the glial or neuronal pathways [41]. The
expression of the miR-9 family of genes is dynamically
regulated [42] during differentiation and development, and
the human miR-9 family has three members: hsa-mir-9-1,
-2, and -3. In the human genome, hsa-mir-9-2 and hsa-
mir-9-3 are intergenic miRNAs, and hsa-mir-9-1 is found
in the second intron of C1orf61. Since the zebrafish ortho-
log of hsa-mir-9-1 is located in an intergenic region, it
qualifies as a ST miRNA based on our definition. More-
over, hsa-mir-9-1 and hsa-mir-9-2 are paralogs that were
most likely separated by the whole-genome duplication at
the root of jawed vertebrates [43-45], which suggests that
their common ancestor was intronic, but that the host
gene is not required for their transcription [17]. Therefore,
all miR-9 family members can be classified as ST miRNAs
and are likely to have their own promoters. A detailed
examination of their genomic environments showed that
all of them share the features of GRB target genes (Figure
4), since they map to genomic regions with high HCNE
densities, the putative promoters of their mouse orthologs
map to bivalent domains and they are all associated with
several proximal CGIs.
We further examined the annotation of each gene
within the investigated region around the miRNAs. Since
there is no other putative GRB target gene within the
region of hsa-mir-9-3, we conclude that hsa-mir-9-3 is
most likely the only target of long-range enhancers in
that region. In the neighborhood of hsa-mir-9-1 and hsa-
mir-9-2, we find myocyte enhancer factors MEF2D and
MEF2C, respectively. Both of these genes are transcrip-
tion factors that play a role in myogenesis and are there-
fore plausible GRB target gene candidates. However, it
was shown that two regions with enhancer activity
located ~10 kb downstream of dre-mir-9-1, the zebrafish
ortholog of hsa-mir-9-1, and ~100 kb downstream of
dre-mir-9-5, the zebrafish ortholog of hsa-mir-9-2, gave
the reporter gene an expression pattern similar to that of
zebrafish miR-9, but not the zebrafish myocyte enhancer
factors [17]. Thus, it may very well be that both miRNAs
and the myocyte enhancer factors are regulated by dis-
tinct elements in the regions, and that there is a bound-
ary between the two, similar to that of neighboring GRBs
targeting PAX6 and WT1 genes [46]. In summary, the
genomic features of regions around members of the miR-
9 family display characteristics equivalent to those of pro-
tein-coding GRB target genes, lending further support to
the use of these features for predicting novel miRNA tar-
gets of long-range regulation.
Genome-wide identification of putative GRB target
miRNAs
Taken together, the results of our analyses show that
HCNE enriched ST miRNA genes are more likely to be
associated with the features of GRB target genes than
HCNE poor ST miRNA genes, which leads us to believe
that we can utilize them for the prediction of GRB tar-
get miRNAs.
Table 2 Comparison of CpG-to-gene ratios between different gene sets
HCNE enriched
miRNAs
HCNE poor
miRNAs
Known GRB target
genes
Known bystander
genes
Other transcription
factors
Other CpG island
genes
Median CpG-to-
gene ratio
0.1703 0.0238 0.2032 0.0100 0.0339 0.0280
p-values:
HCNE enriched
miRNAs
- 0.2931 0.1185 2.7450e-4 0.0124 2.7800e-3
HCNE poor miRNAs 0.2931 - 0.0158 0.1846 0.0966 1.4200e-3
Significant differences in the median CpG-to-gene ratio between the gene sets were determined using the two-sided bootstrapped version of the Kolmogorov-
Smirnov test. Significant p-values (<0.05) are shown in bold. The first row indicates the median CpG-to-gene ratio for each gene set and the second and third
rows contain the p-values of the comparisons between the CpG-to-gene ratios of the HCNE enriched or HCNE poor ST miRNAs and other control gene sets.
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In order to identify GRB target miRNA genes on a
genome-wide scale, we selected all HCNE enriched ST
miRNA genes across different lineage comparisons,
which were associated with bivalent domains in at
least one developmental cell type (Table 3). Our pre-
dictions included 29 ST miRNA genes/miRNA gene
clusters, 19 of which have known functions in develop-
ment (Additional file 5 and Table S3) as well as the
miR-9 family, which are the validated GRB target
miRNAs. We did not use CGI-related features in the
prediction process, since most of the ST miRNAs in
our dataset do not have primary transcript predictions.
We were therefore unable to accurately assign CGIs to
them. Nevertheless, the majority of them are associated
with at least one CGI within the estimated pri-miRNAs
(regions within 50 kb up- and 20 kb downstream of
the pre-miRNAs).
Conclusions
While it has previously been demonstrated that a subset
of miRNA genes are under the same type of extreme
long-range transcriptional regulation typical for develop-
mental transcription factors [17], we were now able to
identify further putative GRB target miRNAs on a gen-
ome-wide scale based on the same characteristics defin-
ing protein-coding GRB target genes. These features are
their localizations in regions with a high HCNE density
and the fact that many of them have “bivalent” promo-
ters before or during differentiation.
Furthermore, the majority of our predictions is known
to play a role during development and is associated with
one or more CGIs that are distributed along the miRNA
primary transcript, indicating that these ST miRNAs
may be subject to the same type of Polycomb-mediated
repression seen in protein coding developmental genes.
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Figure 4 Case study of the miR-9 family. UCSC Genome Browser screen shots of the miRNAs, hsa-mir-9-1 (A), hsa-mir-9-2 (B) and hsa-mir-9-3
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Our results provide an important new resource for the
analysis of miRNA regulation and greatly increase the
number of miRNA genes under putative long-range
transcriptional control, indicating that many miRNAs
are subject to strict regulatory constraints whenever
they are required to establish complex spatiotemporal
developmental patterns.
Methods
Assemblies and annotation
The following genome assemblies were used: human
NCBI 36, mouse NCBI 37 and mouse NCBI 36, chicken
v2.1, Xenopus tropicalis v4.1 (US DoE JOINT genome
Institute), zebrafish Zv7 (The Wellcome Trust Sanger
Institute). Genomic coordinates and sequences of
known miRNAs were obtained from miRBase (Version
12)[1] and the genomic coordinates of HCNEs were
made available from the Ancora database ([29]; http://
ancora.genereg.net; Additional file 6, Table S4). CGI
annotations, Broad Institute Chromatin State Mapping
using ChiP-Seq and genomic sequences were extracted
from the UCSC Genome Browser Database ([47]; http://
genome.ucsc.edu) and gene annotations for human,
mouse and zebrafish were obtained from Ensembl ([48];
http://www.ensembl.org; version 52) using Biomart
([49]; http://www.biomart.org). In addition, because of
Table 3 Annotation of ST miRNA candidates under putative long-range developmental regulation
Name Intergenic/Intragenic Cell type of bivalent promoter 1 Potential alternative GRB target gene 2 CGIs 3
hsa-mir-196b Intergenic mES, MEF HOXA cluster 0
hsa-mir-132~212 Intergenic hES, mES - 1
hsa-mir-196a-2 Intergenic MEF HOXC cluster 2
hsa-mir-9-1 Intron of C1orf61 mES, MEF - -
hsa-mir-9-3 Intergenic hES, mES - 6
hsa-mir-9-2 Intergenic hES MEF2C 8
hsa-mir-10a Intergenic hES, mES, MEF HOXB cluster 1
hsa-mir-196a-1 Intergenic hES HOXB cluster 6
hsa-mir-137 Intergenic hES - 2
hsa-mir-375 Intergenic hES, mES FEV, INN 2
hsa-mir-124-2 Intergenic hES, mES - 3
hsa-mir-542~450b Intergenic hES, mES - 3
hsa-mir-219-2 intergenic hES, mES - 1
hsa-mir-708 Intergenic hES - 1
hsa-mir-365-2 Intergenic hES, mES - 3
hsa-mir-193a Intergenic hES, mES - 3
hsa-mir-129-1 Intergenic hES, mES, MEF - 2
hsa-mir-129-2 intergenic hES, mES, MEF - 3
hsa-mir-124-1 Intergenic hES, mES, MEF - 3
hsa-mir-146b Intergenic hES NFKB2 0
hsa-mir-370 Intergenic hES - 0
hsa-mir-124-3 Intergenic mES, MEF - 3
hsa-mir-17~92a-1 Intergenic MEF - 1
hsa-mir-182~183 Intergenic hES, MEF - 4
hsa-mir-1-1 Intron of C20orf166 mES GATA5 -
hsa-mir-133a-2 Intron of C20orf166 mES GATA5 -
hsa-mir-203 Intergenic mES, MEF - 4
hsa-mir-16-1~15a Intron of DLEU2 mES - -
hsa-let-7a-3~let-7b Intergenic mES WNT7B 3
List of conserved human ST miRNAs that have been annotated as targets of putative long-range regulation during development and differentiation. The mir-9
family of miRNAs is highlighted since it contains know examples of GRB target miRNAs that were captured using our two prediction features: 1) localization in
regions of high HCNE density and 2) association with a bivalent promoter.
1The cell type in which the promoter of the miRNA is predicted to be a bivalent promoter. hES and mES represent embryonic stem cells of human and mouse,
respectively. MEFs are mouse embryonic fibroblasts and NPCs are mouse neural progenitor cells.
2Further annotated GRB target genes within the 300kb region that was analyzed. The annotation of the GRB target genes was performed as described in the
Methods section.
3Number of CpG islands overlapping with pri-miRNAs. The pri-miRNA is defined as the region 50 kb upstream to 20 kb downstream of the pre-miRNAs. If the
defined pri-miRNA overlapped known protein-coding genes (the gene itself plus 1 kb up- and downstream of it), it was truncated to exclude the overlapping
gene (see Methods). We did not count CGIs for intragenic miRNAs (denoted as ‘-’).
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the limited annotation of the zebrafish genome, we also
included zebrafish orthologs of human genes predicted
based on the similarity of exonic sequences and gene
structures between zebrafish and human genomes [50].
The list of putative GRB target genes was constructed
by inspecting HCNE density peaks, tracing the teleost
gene/HCNE synteny, and analyzing functional gene
annotation [25]. GRBs are human-zebrafish synteny
blocks overlapping with GRB target genes. Synteny
blocks were defined through the joined zebrafish to
human high scoring net alignments downloaded from
the UCSC Genome Browser [47].
miRNA classification
Human and zebrafish miRNAs were classified into inter-
genic and intragenic miRNAs based on the overlap of
the pre-miRNA with known protein coding genes (at
least 1 bp overlapping). Our ST miRNAs included both
human intergenic miRNAs and human intragenic miR-
NAs that were intergenic in zebrafish genome, since
these are likely to be self-transcribed. We removed the
Pol III-transcribed miRNAs mentioned by Borchert et al
[30] and subsequently retrieved orthologs of human ST
miRNAs conserved at different evolutionary distances.
For each lineage comparison we clustered human ST
miRNAs into genomic clusters if they were less than 10
kb apart.
Identification of orthologous miRNAs
Orthologs of human ST pre-miRNAs were identified in
seven other species (mouse, dog, opossum, platypus,
chicken, frog and zebrafish). We used BLAST with
default parameters, with the exception of word size,
which was set to six, to compare all known pre-miRNAs
and mature miRNAs between all species. The best reci-
procal BLAST hits highlighted miRNA pairs that were
chosen as putative orthologs. In cases where we could
not find orthologs at the pre-miRNA level, we used the
mature miRNA instead. For precursor orthologs, we
required that the length of the aligned region was equal
to or greater than 56% of the query length and that the
gap-size was no greater than 10.
For orthologs identified via the mature miRNA, we
required that the length of the aligned region was equal
to or greater than 80% of the query length and that the
number of non-matching bases is was no greater than
three. Furthermore, the first two to eight bases had to
be conserved.
Estimating the scale of pri-miRNAs
We used the annotation produced by Saini et al. [14] to
examine the distance between putative miRNA transcrip-
tion start sites/transcription ends and their associated
pre-miRNAs. We found that 93% of the TSSs were
within 50 kb upstream of the pre-miRNAs and 90% of
the miRNA transcription ends lay within 20 kb down-
stream of the pre-miRNAs (Figure 1). These results were
used to define the general span of miRNA transcripts
and extend the analysis window accordingly.
For the analysis of miRNAs with primary transcript
predictions, i.e. the study of CGIs and bivalent promo-
ters, we applied a search window that was the same size
as the predictions from the study mentioned above [14].
Otherwise, the search window was 50 kb upstream and
20 kb downstream of the pre-miRNAs in the CGI analy-
sis and only the region 50 kb upstream of the pre-
miRNA in the bivalent promoter analysis. If the search
window overlapped known/annotated protein-coding
gene regions (the gene itself plus 1 kb up- and down-
stream of it) it was truncated to exclude the overlapping
gene(s).
Analysis of enhancer density
Enhancer (HCNE or p300 binding site) densities were
scanned using a 300 kb sliding window as described in
Engström et al.[29]. For the density of the region around
a sequence feature of interest (TSS for protein-coding
genes), we used the HCNE density value in a 300 kb
window centered on the feature.
We constructed 10000 non-coding/200 protein-coding
control sets by randomly selecting the same number of
coding and non-coding regions in the same genome as
the conserved ST miRNAs. They had distributions of
length, intergenic/intragenic ratio and gene density
equal to that of the conserved ST miRNAs. For the
comparison with GRB target genes, we used the whole
set of GRB target genes.
Separation of ST miRNAs based on HCNE or p300 density
In the analysis of p300 density, we first ordered the
human:mouse conserved ST miRNAs by human:mouse
HCNE densities and mouse:human conserved ST miR-
NAs by p300 binding densities. Then we evenly divided
human and mouse conserved ST miRNAs into two
groups. The top half is located in regions enriched in
HCNE/p300 binding (HCNE/p300 enriched miRNAs),
whereas the remaining ST miRNAs were classified as
being located in regions that are depleted in HCNE/
p300 binding (HCNE/p300 poor miRNAs).
For predicting ST miRNAs that are located in regions
of high HCNE density on a genome-wide scale, we
ordered the conserved ST miRNAs by their HCNE den-
sities, using HCNEs conserved between human and one
of the seven vertebrate species shown in Table S4 and
dividing them into HCNE enriched and HCNE poor ST
miRNAs in the same way as mentioned above.
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Identification of bivalent domains and bivalent promoters
Bivalent domains are regions that are enriched in both
H3K4me3 and H3K27me3 histone modifications at the
same developmental stage and the same tissue. We only
predicted bivalent promoters for intergenic miRNAs
since it was impossible to distinguish whether the fea-
tures were associated with the ST miRNA or the host
gene. Mikkelsen et al. [28] made the mouse histone mod-
ification information available and the human histone
modification information was originally from Pan et al.
[37]. We predicted bivalent promoters of protein-coding
genes and miRNAs using their respective definitions.
Comparison of CpG island features
We compared the CpG island features between HCNE
enriched and HCNE poor miRNAs as well as protein-
coding GRB target genes, bystander genes and two
other control sets, that were comprised of known tran-
scription factors and CGI-associated genes. These gene
sets were taken from the previous study of GRBs by
Akalin et al. [25]. Contrary to this prior work, we only
used the CpG-to-gene ratio in our analyses and not CGI
length and count, since the length of the putative pri-
mary ST miRNAs is much shorter than that of protein-
coding genes (p-value = 1e-03; one-sided Wilcoxon
test). Furthermore, we focused only on miRNAs that
have primary transcript predictions in order to ensure a
high level of accuracy.
Additional material
Additional file 1: Number of human ST miRNAs conserved in
different vertebrate lineages. The number of human ST miRNAs
investigated in our study that is conserved between human and different
vertebrate lineages.
Additional file 2: Enrichment of HCNEs around human ST miRNAs,
conserved in dog (A) and platypus (B). As in Figure 2, the graphs are
cumulative HCNE density curves for conserved human ST miRNAs. The
HCNEs shown here are conserved in dog (A) and platypus (B) as
indicated at the top of each figure pair. In keeping with our results,
conserved human ST miRNAs are more likely to be located in regions
with higher HCNE density than would be expected by chance and this
association extends to the entire vertebrate lineage.
Additional file 3: Enrichment of HCNEs around conserved human ST
miRNAs (excluding ST miRNAs overlapping with GRBs). Each sub-
figure shows the cumulative HCNE density curves for conserved human
ST miRNAs in distinct lineage comparisons, but this time, excluding ST
miRNAs overlapping with known GRBs. These results confirm that
conserved human ST miRNAs are also more likely to be located in
regions with higher HCNE density than would be expected by chance,
independently of their association with any known GRBs and are
therefore most likely the actual target of long-range regulation.
Additional file 4: Number of p300 binding regions overlapping
mouse HCNEs. Total number of p300 binding regions and those
overlapping with mouse HCNEs (with percentage of identity larger than
98% and length longer than 50 bp) in three mouse embryonic tissues.
Additional file 5: Functional annotation of miRNAs under putative
long-range regulation. Functional information regarding the miRNA
candidates we annotated as being under putative long-range regulation.
Additional file 6: The percentage of identity and length cutoffs of
HCNEs. The lineage comparisons, percentage of identity and length cut-
offs used to determine the HCNEs in our study.
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